ANI Pharma Inc (ANIP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2002 | 12-2001 | 09-2001 | 06-2001 | 03-2001 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,103 | -2,611 | -1,200 | -1,549 | -690 |
| Depreciation Amortization | 23 | 93 | 70 | 49 | 24 |
| Other Working Capital | -241 | 677 | 662 | 1 | -129 |
| Other Operating Activity | 0 | 18 | 18 | 18 | 9 |
| Operating Cash Flow | $-1,322 | $-1,824 | $-450 | $-1,482 | $-786 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -17 | -87 | -76 | -23 | -2 |
| Investing Cash Flow | $-17 | $-87 | $-76 | $-23 | $-2 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | -1 | 3,801 | 3,893 | 3,675 | 3,398 |
| Financing Cash Flow | $-1 | $3,801 | $3,893 | $3,675 | $3,398 |
| Beginning Cash Position | 4,502 | 2,612 | 2,612 | 2,612 | 2,612 |
| End Cash Position | 3,163 | 4,502 | 5,979 | 4,782 | 5,222 |
| Net Cash Flow | $-1,340 | $1,891 | $3,367 | $2,170 | $2,610 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,322 | -1,824 | -450 | -1,482 | -786 |
| Capital Expenditure | -17 | -87 | -76 | -23 | -2 |
| Free Cash Flow | -1,338 | -1,911 | -526 | -1,504 | -788 |